Neurogene Inc.
No enriched coverage for $NGNE in the last 7 days.
No SEC Form 4 filings for $NGNE in the last 30 days.
See all $NGNE insider activity →Neurogene Inc. (NGNE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 ngne-june2026cmpoxunderwri.htm EX-1.1 Document NEUROGENE INC. (a Delaware corporation) 3,500,000 Shares of Common Stock Pre-Funded Warrants to purchase up to 666,666 shares of Common Stock UNDERWRITING AGREEMENT June 30, 2026 Leerink Partners LLC Stifel, Nicolaus & Compa
The 8-K discloses a new equity offering structure (common shares + pre-funded warrants + underwriter option), which can pressure near-term dilution expectations.
alphai scores every news story that mentions NGNE with an AI model for sentiment and relevance, and aggregates insider trades from Neurogene Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Neurogene Inc. (NGNE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 ngne-june2026cmpoxunderwri.htm EX-1.1 Document NEUROGENE INC. (a Delaware corporation) 3,500,000 Shares of Common Stock Pre-Funded Warrants to purchase up to 666,666 shares of Common Stock UNDERWRITING AGREEMENT June 30, 2026 Leerink Partners LLC Stifel, Nicolaus & Compa
3 min read